| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1497295B1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1482948B1 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 08/16/2006 | EP1478352B1 Pharmaceutical dosage form and method for the production thereof |
| 08/16/2006 | EP1469827A4 Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| 08/16/2006 | EP1467707B1 Composition for easing human childbirth |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1404678B1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 08/16/2006 | EP1401425B1 Organometallic anti-tumour agent |
| 08/16/2006 | EP1385578B1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1363892B1 Method for the production of a stable pharmaceutical form of paclitaxel |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1301467B1 9-substituted minocycline compounds |
| 08/16/2006 | EP1296647B1 Polymeric micelle compositions |
| 08/16/2006 | EP1294920B1 Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same |
| 08/16/2006 | EP1276471B1 Membrane delivery system |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1227810B8 Treating cancer by increasing intracellular malonyl coa levels |
| 08/16/2006 | EP1220908B1 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 08/16/2006 | EP1220670B1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1196179B1 Hyaluronic acid esters for the treatment of normotrophic scarring of the skin |
| 08/16/2006 | EP1191019B1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1181020B1 Vitamin d derivatives for the teatment of systemic lupus erythematosus |
| 08/16/2006 | EP1171123B1 Method for treating neurodegeneration |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1123120B1 Medicinal aerosol formulation |
| 08/16/2006 | EP1107958B1 Pyrimidine compounds |
| 08/16/2006 | EP1094799B1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1025844B1 L-valine for hepatic diseases |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0977577B1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 08/16/2006 | EP0972037B1 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 08/16/2006 | EP0964677B1 Sustained analgesia achieved with transdermal delivery of buprenorphine |
| 08/16/2006 | EP0952828B1 Therapeutic uses for nitric oxide inhibitors |
| 08/16/2006 | EP0917873B1 Eyedrops |
| 08/16/2006 | EP0888326B1 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | EP0527917B2 Use of adenosine and adenosine derivatives for anesthesia |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820074A SiRNA expression system |
| 08/16/2006 | CN1820017A Macrolides substituted at the 4''-position |
| 08/16/2006 | CN1820016A Novel 14 and 15 membered-ring compounds |
| 08/16/2006 | CN1820012A Organosilicon compounds and their use |
| 08/16/2006 | CN1820011A Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/16/2006 | CN1820010A Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 08/16/2006 | CN1820009A Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 08/16/2006 | CN1820008A Substituted quinolin-4-ylamine analogues |
| 08/16/2006 | CN1820007A Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 08/16/2006 | CN1820004A Benzofuran derivatives and their use in the treatment of microbial infections |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
| 08/16/2006 | CN1819996A Naphthylene derivatives as cytochrome P450 inhibitors |
| 08/16/2006 | CN1819995A Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 08/16/2006 | CN1819994A KAPPA agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/16/2006 | CN1819990A Compound having anti-hcv activity and process for producing the same |
| 08/16/2006 | CN1819846A Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819842A Treating effect of using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 08/16/2006 | CN1819834A Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819832A Therapeutic phosphonate compounds |
| 08/16/2006 | CN1819831A Cancer combination therapy comprising AZD217 and ZD1839 |
| 08/16/2006 | CN1819830A Combination therapy |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1819828A Nasal pharmaceutical composition of piribedil |
| 08/16/2006 | CN1819827A Further therapeutic use of zolpidem |
| 08/16/2006 | CN1819826A Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819824A Use of an antioxidant in a dermatological and/or cosmetic composition |
| 08/16/2006 | CN1819823A Orodispersible pharmaceutical composition of an antithrombotic compound |
| 08/16/2006 | CN1819822A Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use |
| 08/16/2006 | CN1819820A Pharmaceutical formulation comprising levothyroxine sodium |
| 08/16/2006 | CN1819817A The solid dispersion of tacrolimus |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817898A Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound |
| 08/16/2006 | CN1817896A Compounds like quercetol and metal complex of their glycosides and uses |
| 08/16/2006 | CN1817889A Antiviral medicine with rare earth of heteropoly compound |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/16/2006 | CN1817881A Production of stilsarin coarse products |
| 08/16/2006 | CN1817880A 2-bit-substituted quinolone compound and use in pharmacey |
| 08/16/2006 | CN1817873A Flavane compound and use thereof |
| 08/16/2006 | CN1817868A Group of ornidazole deriative for preventing anaerobe infection and production thereof |
| 08/16/2006 | CN1817866A Group of geldanamycin derivative with nucleoside base |